SKI Market

A+| A| A-|

Indian Indices

Sensex

77,269.40 355.90
( 0.46%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kay Cee Energy & Infra Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

92425

INE0RCG01017

70.9391361

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KCEIL

9.07

154.76

EPS(TTM)

Face Value()

Div & Yield %

13.96

Back

Shree Ganesh Biotech India standalone net profit declines 96.88% in the September 2025 quarter

Nov 08,2025

Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.77	1.98	-61
OPM %	-51.95	1.01	-
PBDT	0.01	0.32	-97
PBT	0.01	0.32	-97
NP	0.01	0.32	-97

77,269.40 355.90 ( 0.46%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)